Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Khozoie, Combiz ^a   Borland, Michael G ^a,c   Zhu, Bokai ^a   Baek, Songjoon ^b   John, Sam ^b,d   Hager, Gordon L ^b   Shah, Yatrik M ^b,e   Gonzalez, Frank J ^b   Peters, Jeffrey M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BLOOMSBURG UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Gene expression; Keratinocytes; Peroxisome proliferator activated receptor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; RECEPTOR OCCUPANCY; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

ACTIVATING TRANSCRIPTION FACTOR 4; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CHROMATIN; DNA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOMICS; KERATINOCYTES; MICE; PPAR DELTA; PPAR-BETA; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

EID: 84869861265     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-665     Document Type: Article

References (60)

1. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006, 126:789-799. 10.1016/j.cell.2006.06.049, 16923397.
2. Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM. Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice. Biochem Biophys Res Commun 2008, 371:456-461. 10.1016/j.bbrc.2008.04.086, 2586836, 18442472.
3. Modica S, Gofflot F, Murzilli S, D'Orazio A, Salvatore L, Pellegrini F, Nicolucci A, Tognoni G, Copetti M, Valanzano R, et al. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology 2010, 138:636-648. 648, 10.1053/j.gastro.2009.09.060, 19818784.
4. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010, 28:1248-1250. 10.1038/nbt1210-1248, 21139605.
5. Burdick AD, Kim DJ, Peraza MA, Gonzalez FJ, Peters JM. The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation. Cell Signal 2006, 18:9-20. 10.1016/j.cellsig.2005.07.009, 16109478.
6. Peters JM, Foreman JE, Gonzalez FJ. Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast and lung carcinogenesis. Cancer Metastasis Rev 2011, 30:619-640. 10.1007/s10555-011-9320-1, 3237866, 22037942.
7. Peters JM, Gonzalez FJ. Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer. Biochim Biophys Acta 2009, 1796:230-241. 2762441, 19505534.
8. Peters JM, Hollingshead HE, Gonzalez FJ. Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease. Clin Sci (Lond) 2008, 115:107-127.
9. Peters JM, Shah YM, Gonzales FJ. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat Rev Cancer 2012, 12:181-195.
10. Peters JM, Morales JL, Gonzales FJ. Modulation of gastrointestinal inflammation and colorectal tumorigenesis by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ). Drug Discovery Today: Disease Mechanisms 2011, 8:e85-e93. 10.1016/j.ddmec.2011.11.002, 3352671, 22611424.
11. Kilgore KS, Billin AN. PPARβ/δ ligands as modulators of the inflammatory response. Curr Opin Investig Drugs 2008, 9:463-469.
12. Billin AN. PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home. Expert Opin Investig Drugs 2008, 17:1465-1471. 10.1517/13543784.17.10.1465, 18808307.
13. Adhikary T, Kaddatz K, Finkernagel F, Schonbauer A, Meissner W, Scharfe M, Jarek M, Blocker H, Muller-Brusselbach S, Muller R. Genomewide analyses define different modes of transcriptional regulation by peroxisome proliferator-activated receptor-β/δ (PPARβ/δ). PLoS One 2011, 6:e16344. 10.1371/journal.pone.0016344, 3023804, 21283829.
14. Shi Y, Hon M, Evans RM. The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci U S A 2002, 99:2613-2618. 10.1073/pnas.052707099, 122396, 11867749.
15. Biddie SC, Hager GL. Glucocorticoid receptor dynamics and gene regulation. Stress 2009, 12:193-205. 10.1080/10253890802506409, 19051126.
16. Biddie SC, John S, Hager GL. Genome-wide mechanisms of nuclear receptor action. Trends Endocrinol Metab 2010, 21:3-9. 10.1016/j.tem.2009.08.006, 2818176, 19800253.
17. Hager GL, Varticovski L. Chromatin in time and space. Biochim Biophys Acta 2012, 1819:631. 10.1016/j.bbagrm.2012.05.002, 22677544.
18. McNally JG, Muller WG, Walker D, Wolford R, Hager GL. The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 2000, 287:1262-1265. 10.1126/science.287.5456.1262, 10678832.
19. Chawla A, Lee CH, Barak Y, He W, Rosenfeld J, Liao D, Han J, Kang H, Evans RM. PPARδ is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci U S A 2003, 100:1268-1273. 10.1073/pnas.0337331100, 298762, 12540828.
20. Hollingshead HE, Borland MG, Billin AN, Willson TM, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 2008, 29:169-176.
21. Mandard S, Zandbergen F, Tan NS, Escher P, Patsouris D, Koenig W, Kleemann R, Bakker A, Veenman F, Wahli W, et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 2004, 279:34411-34420. 10.1074/jbc.M403058200, 15190076.
22. Heinaniemi M, Carlberg C. Screening for PPAR Responsive Regulatory Modules in Cancer. PPAR Res 2008, 2008:749073. 2422871, 18551184.
23. Heinaniemi M, Uski JO, Degenhardt T, Carlberg C. Meta-analysis of primary target genes of peroxisome proliferator-activated receptors. Genome Biol 2007, 8:R147. 10.1186/gb-2007-8-7-r147, 2323243, 17650321.
24. Lemay DG, Hwang DH. Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics. J Lipid Res 2006, 47:1583-1587. 10.1194/jlr.M500504-JLR200, 16585784.
25. Bugge A, Mandrup S. Molecular mechanisms and genome-wide aspects of PPAR subtype specific Transactivation. PPAR Res 2010, 169506. 2010.
26. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Borgesen M, Francoijs KJ, Mandrup S, et al. Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 2008, 22:2953-2967. 10.1101/gad.501108, 2577787, 18981474.
27. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
28. Thomas PD, Kejariwal A, Campbell MJ, Mi H, Diemer K, Guo N, Ladunga I, Ulitsky-Lazareva B, Muruganujan A, Rabkin S, et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003, 31:334-341. 10.1093/nar/gkg115, 165562, 12520017.
29. Venkatachalam G, Kumar AP, Yue LS, Pervaiz S, Clement MV, Sakharkar MK. Computational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human. BMC genomics 2009, 10(Suppl 3):S5. 10.1186/1471-2164-10-S3-S5, 2788392, 19958503.
30. Mahony S, Benos PV. STAMP: a web tool for exploring DNA-binding motif similarities. Nucleic Acids Res 2007, 35:W253-W258. 10.1093/nar/gkm272, 1933206, 17478497.
31. Yuspa SH, Morgan DL. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature 1981, 293:72-74. 10.1038/293072a0, 6791032.
32. Kim DJ, Bility MT, Billin AN, Willson TM, Gonzalez FJ, Peters JM. PPARβ/δ selectively induces differentiation and inhibits cell proliferation. Cell Death Differ 2006, 13:53-60. 10.1038/sj.cdd.4401713, 16021179.
33. Kim DJ, Murray IA, Burns AM, Gonzalez FJ, Perdew GH, Peters JM. Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits epidermal cell proliferation by down-regulation of kinase activity. J Biol Chem 2005, 280:9519-9527.
34. Man MQ, Barish GD, Schmuth M, Crumrine D, Barak Y, Chang S, Jiang Y, Evans RM, Elias PM, Feingold KR. Deficiency of PPARβ/δ in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 2007, 128:370-377.
35. Peters JM, Lee SST, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ. Growth, adipose, brain and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β/δ. Mol Cell Biol 2000, 20:5119-5128. 10.1128/MCB.20.14.5119-5128.2000, 85961, 10866668.
36. Schmuth M, Haqq CM, Cairns WJ, Holder JC, Dorsam S, Chang S, Lau P, Fowler AJ, Chuang G, Moser AH, et al. Peroxisome proliferator-activated receptor (PPAR)-β/δ stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 2004, 122:971-983. 10.1111/j.0022-202X.2004.22412.x, 15102088.
37. Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, Schroder HD, Kratchmarova I, Berge RK, Iversen L, Bolund L, et al. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 2001, 116:702-712. 10.1046/j.1523-1747.2001.01329.x, 11348458.
38. Burdick AD, Bility MT, Girroir EE, Billin AN, Willson TM, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes. Cell Signal 2007, 19:1163-1171. 10.1016/j.cellsig.2006.12.007, 1913217, 17254750.
39. Di-Poi N, Tan NS, Michalik L, Wahli W, Desvergne B. Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Molecular Cell 2002, 10:721-733. 10.1016/S1097-2765(02)00646-9, 12419217.
40. Romanowska M, al Yacoub N, Seidel H, Donandt S, Gerken H, Phillip S, Haritonova N, Artuc M, Schweiger S, Sterry W, et al. PPARδ enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol 2008, 128:110-124. 10.1038/sj.jid.5700943, 17637826.
41. Romanowska M, Reilly L, Palmer CN, Gustafsson MC, Foerster J. Activation of PPARβ/δ causes a psoriasis-like skin disease in vivo. PLoS One 2010, 5:e9701. 10.1371/journal.pone.0009701, 2838790, 20300524.
42. Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999, 3:397-403. 10.1016/S1097-2765(00)80467-0, 10198642.
43. Fyffe SA, Alphey MS, Buetow L, Smith TK, Ferguson MA, Sorensen MD, Bjorkling F, Hunter WN. Reevaluation of the PPAR-β/δ ligand binding domain model reveals why it exhibits the activated form. Mol Cell 2006, 21:1-2. 10.1016/j.molcel.2005.12.001, 16387648.
44. Hollingshead BD, Beischlag TV, Dinatale BC, Ramadoss P, Perdew GH. Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells. Cancer Res 2008, 68:3609-3617. 10.1158/0008-5472.CAN-07-6168, 2568985, 18483242.
45. Boros J, Donaldson IJ, O'Donnell A, Odrowaz ZA, Zeef L, Lupien M, Meyer CA, Liu XS, Brown M, Sharrocks AD. Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res 2009, 19:1963-1973. 10.1101/gr.093047.109, 2775591, 19687146.
46. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43. 10.1016/j.cell.2005.05.008, 16009131.
47. Ji Z, Donaldson IJ, Liu J, Hayes A, Zeef LA, Sharrocks AD. The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation. Mol Cell Biol 2012, 32:385-398. 10.1128/MCB.05504-11, 3255788, 22083952.
48. Dlugosz AA, Glick AB, Tennenbaum T, Weinberg WC, Yuspa SH. Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol 1995, 254:3-20.
49. Do JH, Choi DK. Normalization of microarray data: single-labeled and dual-labeled arrays. Mol Cells 2006, 22:254-261.
50. Zhu B, Khozoie C, Bility MT, Ferry CH, Blazanin N, Glick AB, Gonzalez FJ, Peters JM. Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells. Mol Cell Biol 2012, 32:2065-2082. 10.1128/MCB.00092-12, 3372236, 22473992.
51. Palkar PS, Borland MG, Naruhn S, Ferry CH, Lee C, Sk UH, Sharma AK, Amin S, Murray IA, Anderson CR, et al. Cellular and Pharmacological Selectivity of the PPARβ/δ Antagonist GSK3787. Mol Pharmacol 2010, 78:419-430. 10.1124/mol.110.065508, 2939490, 20516370.
52. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562. 10.1038/nature01262, 12466850.
53. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10:R25. 10.1186/gb-2009-10-3-r25, 2690996, 19261174.
54. Baek S, Sung MH, Hager GL. Quantitative analysis of genome-wide chromatin remodeling. Methods Mol Biol (Clifton, NJ) 2012, 833:433-441.
55. Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y, Shin H, Wong SS, Ma J, Lei Y, et al. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol 2011, 12:R83. 10.1186/gb-2011-12-8-r83, 3245621, 21859476.
56. He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet 2010, 42:343-347. 10.1038/ng.545, 2932437, 20208536.
57. Felsenstein J. PHYLIP (Phylogeny Inference Package) version 3.6 2005, Seattle, WA, USA: Distributed by the author, Department of Genetics, University of Washington, 36th, Retrieved from http://evolution.genetics.washington.edu/phylip/.
58. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739. 10.1093/molbev/msr121, 3203626, 21546353.
59. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13. 10.1093/nar/gkn923, 2615629, 19033363.
60. Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2010, 38:D204-D210. 10.1093/nar/gkp1019, 2808919, 20015972.